Sirtuins

Sirtuin inhibitors and activators target the seven mammalian sirtuins, a family of protein deacetylases. Yeast silent information regulator 2 (Sir2), the founding member, is a histone deacetylase that requires nicotinamide adenine dinucleotide (NAD+). Human sirtuins (SIRT1 to SIRT7) differ in location, with SIRT1 mainly nuclear, SIRT2 mainly cytoplasmic and SIRT3 to SIRT5 in mitochondria. Selisistat, also known as EX-527, inhibits SIRT1, and SirReal2 selectively inhibits SIRT2. SRT1720 HCl and SRT2104 are described as synthetic SIRT1 activators. Nicotinamide, a product of the sirtuin reaction, inhibits sirtuin activity, while nicotinamide riboside is a precursor of NAD+.

Items 76-92 of 92

  • AGK7
    Cat. No.
    A57013

    AGK7

    Synonyms: SIRT2 Inhibitor; Inactive Control

    AGK7 is a selective inhibitor of sirtuin 2 (SIRT2), demonstrating significant neuroprotective effects in the context of Parkinson's disease. This compound has been shown to alleviate alpha-synuclein toxicity and improve inclusion morphology in cellular models. In addition, AGK7 effectively protects against dopaminergic cell death in both in vitro studies and Drosophila models, making it a valuable tool for researching neurodegenerative disorders.

    1 mg
    $50.00
    5 mg
    $100.00
    All 4 sizes
  • SIRT-IN-5
    Cat. No.
    A57014

    SIRT-IN-5

    SIRT-IN-5 is a selective inhibitor of SIRT3, demonstrating an IC50 value of 2.88 μM. This compound has been shown to promote the differentiation of multiple myeloma cells, facilitating increased expression of differentiation antigens such as CD49e, as well as enhancement of human immunoglobulin light chains λ and κ. SIRT-IN-5 is a valuable tool in research focused on the modulation of cellular differentiation processes in hematological malignancies.

    Out of stock

    All 3 sizes
  • Sirtuin-IN-1
    Cat. No.
    A57015

    Sirtuin-IN-1

    Sirtuin-IN-1 is a selective inhibitor of SIRT1 and SIRT2, with IC50 values of 6.2 μM and 4.2 μM, respectively. This compound has been shown to induce G1 phase cell cycle arrest, demonstrating its potential as an anti-cancer agent. Sirtuin-IN-1 is particularly effective against glioma, making it a valuable tool for research into cancer therapeutics and the exploration of sirtuin-related biological pathways.

    Out of stock

    All 3 sizes
  • Sirtuin modulator 4
    Cat. No.
    A57016

    Sirtuin modulator 4

    Sirtuin Modulator 4 is a selective SIRT1 inhibitor, demonstrating an EC50 value of 51-100 μM. This compound plays a critical role in modulating cellular pathways associated with lifespan extension and offers potential in researching a variety of conditions, including diabetes, obesity, neurodegenerative diseases, cardiovascular disorders, inflammation, and cancer. Its ability to inhibit SIRT1 makes it a valuable tool for studying the therapeutic implications of sirtuin regulation in metabolic and age-related diseases.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SIRT2-IN-14
    Cat. No.
    A57018

    SIRT2-IN-14

    SIRT2-IN-14 is a selective inhibitor of SIRT2, demonstrating an IC50 value of 0.196 μM. This compound effectively modulates SIRT2 activity, making it a valuable tool for studying the role of SIRT2 in various biological pathways. Research applications may include investigations into neurodegenerative diseases, cancer biology, and cellular metabolism, providing insights into the therapeutic potential of targeting SIRT2.

    Out of stock

    All 3 sizes
  • SIRT5 inhibitor 2
    Cat. No.
    A57020

    SIRT5 inhibitor 2

    SIRT5 inhibitor 2 is a selective inhibitor of the SIRT5 enzyme, exhibiting an IC50 value of 2.3 μM. It effectively inhibits SIRT5-dependent desuccinylation processes, making it a valuable tool for investigating the roles of SIRT5 in various biological contexts. This compound is suitable for research applications focusing on cancer biology and neurodegenerative diseases, aiding in the exploration of therapeutic strategies targeting SIRT5 activity.

    1 mg
    $235.00
    5 mg
    $590.00
    All 6 sizes
  • ZINC08792355
    Cat. No.
    A57022

    ZINC08792355

    ZINC08792355 is a selective SIRT1 inhibitor that plays a crucial role in the regulation of cellular processes associated with aging, metabolic disorders, and oncogenesis. This compound facilitates the exploration of SIRT1-related pathways in research on age-related diseases, diabetes, and cancer, making it a valuable tool for investigators studying these important biological phenomena.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes
  • SR94
    Cat. No.
    A57024

    SR94

    SR94 is a selective SIRT2 inhibitor that features a unique six-membered ring structure with variable R2 substituents. This compound demonstrates potential in the investigation of cancer, ischemia-reperfusion injury, and neurodegenerative diseases. Its targeted inhibition of SIRT2 makes it a valuable tool for understanding the role of this enzyme in various biological processes and disease states.

    1 mg
    $65.00
    5 mg
    $150.00
    All 7 sizes
  • SIRT5 inhibitor 7
    Cat. No.
    A57027

    SIRT5 inhibitor 7

    SIRT5 Inhibitor 7 is a selective substrate-competitive inhibitor targeting SIRT5, known for its anti-inflammatory properties. This compound effectively regulates protein succinylation and reduces the release of pro-inflammatory cytokines, offering potential renal protective effects. SIRT5 Inhibitor 7 demonstrates notable in vivo efficacy in mouse models of acute kidney injury induced by lipopolysaccharide (LPS) and cecal ligation/perforation (CLP), making it a valuable tool for researching sepsis-related kidney damage.

    1 mg
    $280.00
    5 mg
    $850.00
    All 6 sizes
  • ZINC08792229
    Cat. No.
    A57032

    ZINC08792229

    ZINC08792229 is a potent inhibitor of SIRT1, a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase playing a crucial role in cellular regulation. This compound exhibits significant biological activity that may contribute to research on SIRT1-related diseases, including aging, diabetes, and cancer. It serves as a valuable tool for exploring the therapeutic potential of targeting SIRT1 in various pathological conditions.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes
  • Aristoforin
    Cat. No.
    A57033

    Aristoforin

    Aristoforin, a hypericin derivative, selectively inhibits SIRT1 and SIRT2, resulting in G1 phase cell cycle arrest. This compound also scavenges hydroxyl free radicals and demonstrates protective effects against Fe2+-induced DNA breakage. Aristoforin is valuable for research in the context of breast cancer and colon adenocarcinoma studies.

    25 mg
    $2,915.00
    50 mg
    $3,755.00
    All 3 sizes
  • SIRT3-IN-2
    Cat. No.
    A57035

    SIRT3-IN-2

    SIRT3-IN-2 is a selective inhibitor of the SIRT3 enzyme, demonstrating a reduction of SIRT3 activity by 39% at a concentration of 200 µM. This compound is valuable for investigations into metabolic homeostasis and its implications in tumor suppression. SIRT3-IN-2 can be utilized in research aimed at understanding the regulatory roles of sirtuins in cellular metabolism and cancer biology.

    1 mg
    $65.00
    5 mg
    $260.00
    All 4 sizes
  • SIRT2-IN-15
    Cat. No.
    A57036

    SIRT2-IN-15

    SIRT2-IN-15 is a selective inhibitor of the SIRT2 deacetylase and deamyloacylase enzymes, demonstrating IC50 values of 7 μM and 37 μM, respectively. This compound modulates cellular acetylation states, making it a valuable tool for investigating the roles of SIRT2 in various biological processes, including neurodegenerative diseases, cancer metabolism, and aging. SIRT2-IN-15 can be utilized in research applications focusing on the molecular mechanisms of SIRT2-related pathways and potential therapeutic targets.

    25 mg
    $1,395.00
    50 mg
    $1,860.00
    All 3 sizes
  • A2B57
    Cat. No.
    A57038

    A2B57

    A2B57 is a selective inhibitor of SIRT2, exhibiting an IC50 value of 6.3 µM. This compound effectively modulates the activity of SIRT2, making it a valuable tool for exploring the role of this enzyme in various biological processes. Its application extends to studies in neurodegeneration, metabolism, and cellular stress responses, providing insights into SIRT2-related pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SIRT-IN-6
    Cat. No.
    A57039

    SIRT-IN-6

    SIRT-IN-6 is a pan-inhibitor targeting SIRT1, SIRT2, and SIRT3, with IC50 values exceeding 50 μM. This compound is valuable for studying its effects in metabolic, inflammatory, oncologic, and neurodegenerative disorders. Its broad inhibition profile makes it a suitable tool for elucidating the roles of sirtuins in various biological processes and disease states.

    25 mg
    $80.00
    50 mg
    $115.00
    All 5 sizes
  • A1B11
    Cat. No.
    A57040

    A1B11

    A1B11 is a selective inhibitor of Sirtuin 2 (SIRT2) with an IC50 value of 5.3 μM. This compound is primarily utilized in research focused on neurodegenerative diseases, where SIRT2 modulation plays a critical role in the underlying mechanisms of pathology. A1B11 provides a valuable tool for investigating the therapeutic potential of SIRT2 inhibition in various neurodegenerative conditions.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • MIND4
    Cat. No.
    A98880

    MIND4

    MIND4 is a selective SIRT2 inhibitor known for its neuroprotective properties. This thiozoline compound also functions as an inducer and activator of the nuclear factor NRF2, promoting antioxidant responses. MIND4 effectively induces NRF2 activation in both neuronal and non-neuronal cells, leading to a decrease in reactive oxygen and nitrogen species production. This makes MIND4 a valuable tool for research focusing on neuroprotection and oxidative stress responses.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes

Items 76-92 of 92

Added to your cart

View Cart Checkout

    Loading...